COLOPLAST A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 832.2 DKK | -2.46% |
|
-1.23% | +8.08% |
| 06-06 | Transcript : Coloplast A/S - Analyst/Investor Day | |
| 05-15 | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |  |
Presenter SpeechAleksandra Dimovska (Executives)Hi, everyone. I hope the sound is okay, and my...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
20/08/2024
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
853.2
DKK
Average target price
897.4
DKK
Spread / Average Target
+5.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.08% | 27.57B | |
| +32.96% | 2.6B | |
| -42.58% | 2.6B | |
| +8.22% | 2.26B | |
| -26.44% | 2.2B | |
| +30.00% | 1.99B | |
| -8.95% | 1.92B | |
| +35.14% | 1.35B | |
| +0.21% | 1.28B | |
| +18.92% | 1.24B |
- Stock Market
- Equities
- COLO B Stock
- News Coloplast A/S
- Transcript : Coloplast A/S - Analyst/Investor Day
